Verification of effective Zika virus reduction by production steps used in the manufacture of plasma-derived medicinal products.

Roth, Nathan J; Schäfer, Wolfram; Popp, Birgit; Stucki, Martin; Fang, Randel

Roth, Nathan J; Schäfer, Wolfram; Popp, Birgit; Stucki, Martin; Fang, Randel.

Afiliação

Roth NJ; Global Pathogen Safety, CSL Behring, King of Prussia, PA.
Schäfer W; CSL Behring AG, Bern, Switzerland.
Popp B; Global Pathogen Safety, CSL Behring, King of Prussia, PA.
Stucki M; CSL Behring GmbH, Marburg, Germany.
Fang R; Global Pathogen Safety, CSL Behring, King of Prussia, PA.

Transfusion ; 57(3): 720-721, 2017 03.

Article em En | MEDLINE | ID: mdl-28297081

Assuntos

Plasma; Zika virus; Comércio; Infecção por Zika virus

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Plasma / Zika virus Idioma: En Revista: Transfusion Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Panamá

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google